| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_00e4b5d6861ab0670a21e7f962c67e0a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55561
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-572
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-295
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
| filingDate |
2016-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b58ad85747ddfffc7ae448d21654a1d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53f383e012a83066e34e89f7ad5a19db
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_108ca289936614a7dd246c41b54bd5c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae0bf6917b6a5b01dcf0f62877c0b079
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b42010b8926e0f1b61c48cce10d85ab |
| publicationDate |
2016-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2016106117-A |
| titleOfInvention |
Chlamydia antigen and uses thereof |
| abstract |
An immunogenic composition (eg, vaccine) comprising an isolated chlamydia antigen. The present invention provides novel chlamydia antigens, nucleic acids encoding such antigens, and immunogenic compositions comprising such antigens. The invention further provides methods of using such antigens to elicit an immune response (eg, a T cell mediated and / or B cell mediated immune response). The present invention provides a method for preventing and / or treating a chlamydia-mediated disease comprising administering an immunogenic composition comprising one or more of the novel antigens described herein. . [Selection figure] None |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10780990-B2 |
| priorityDate |
2010-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |